Primary Dysmenorrhea
Definition: Menstrual pain in the absence of underlying pelvic pathology. It affects up to 90% of menstruating women and is one of the leading causes of absenteeism in young women. It usually begins within 6-24 months of menarche, once ovulatory cycles are established, and most often affects younger women, though it can persist into the 40s (Berek & Novak's Gynecology, p. 571; Swanson's Family Medicine Review, p. 405).
Pathophysiology (brief)
Falling progesterone in the late luteal phase triggers release of arachidonic acid and prostaglandins (especially PGF2α) from the endometrium via the COX pathway. Excess prostaglandins/thromboxane cause high-amplitude uterine contractions, increased basal tone, decreased uterine blood flow, and peripheral nerve sensitization - this is why NSAIDs (COX inhibitors) work so well.
Symptoms
- Pain begins a few hours before or just after onset of menstrual flow, peaks with heaviest flow, and lasts 48-72 hours
- Suprapubic, labor-like colicky cramping
- May radiate to the lumbosacral back and anterior thighs
- Associated nausea, vomiting, diarrhea, headache, fatigue, and rarely syncope
- Pain is relieved by movement, counterpressure, or abdominal massage (unlike pain from peritonitis)
Signs (key to diagnosis)
- Normal vital signs
- Suprapubic tenderness only; no abdominal rebound or peritoneal signs
- Bimanual exam may show mild uterine tenderness during the episode, but no cervical motion tenderness or adnexal tenderness
- Pelvic organs are structurally normal
Diagnosis
Primary dysmenorrhea is a clinical diagnosis of exclusion:
- History to exclude abnormal bleeding, dyspareunia, or non-midline focal pain (which suggest secondary causes)
- Pelvic exam assessing uterine size/mobility, adnexal tenderness, and uterosacral nodularity - should be normal
- NAAT for gonorrhea/chlamydia (+/- CBC, ESR) to rule out PID/endometritis
- Pelvic ultrasound reserved for cases that don't resolve with NSAIDs
- Laparoscopy is not required if the above is unremarkable
Management
First-line - NSAIDs: Prostaglandin synthase inhibitors are highly effective.
- Start 1-3 days before expected menses (or at first sign of bleeding/pain if cycles are irregular)
- Continue dosing every 6-8 hours through the first few days of flow to suppress ongoing prostaglandin production
- Give a 4-6 month trial before declaring treatment failure; switch to a different NSAID class if one fails
- Contraindicated with GI ulcer disease or aspirin-exacerbated respiratory disease; side effects are usually mild (nausea, dyspepsia, diarrhea, fatigue)
First-line alternative/adjunct - Hormonal contraception: Equally effective as NSAIDs.
- Combined estrogen-progestin or progestin-only pills (cyclic or continuous), transdermal patch, vaginal ring, injectable progestins, or the levonorgestrel IUD
- Best choice for patients who also want contraception or who fail/cannot use NSAIDs
Adjunct/second-line options:
- Combining NSAIDs with hormonal contraceptives if either alone is insufficient
- Heat application, exercise, and lifestyle measures for mild symptomatic relief
- Complementary options with some supporting evidence: vitamin B1 (thiamine, 100 mg/day), magnesium, omega-3 fatty acid supplementation (fish oil), and ginger (per recent meta-analyses, see below) - useful as adjuncts, especially for NSAID-intolerant patients
- Failure rate of conventional treatment is roughly 20-25%, which is why patients often try these alternatives
Rarely used (reserved for refractory cases):
- Laparoscopic uterine nerve ablation (LUNA), presacral neurectomy, or hysterectomy
- Evidence for spinal manipulation is negative (Cochrane review found no benefit for primary or secondary dysmenorrhea)
If pain does not respond to an adequate NSAID/hormonal trial, or if exam/history features suggest pathology, evaluation shifts toward ruling out secondary dysmenorrhea (endometriosis, adenomyosis, fibroids, etc.).
Recent evidence (supplementary, not yet in textbooks)
A quick check of recent systematic reviews/meta-analyses (last ~2-3 years) on primary dysmenorrhea found supportive but lower-certainty evidence for several non-pharmacologic adjuncts:
- Manual therapy and electrotherapy techniques (massage, TENS) showed modest benefit in a 2024 systematic review/meta-analysis (PMID: 38366860)
- Ginger showed pain-reducing effects comparable to NSAIDs in some trials per a 2024 meta-analysis (PMID: 38770631)
- Moxibustion also showed benefit in a 2025 systematic review (PMID: 40046934)
These support NSAIDs/hormonal contraception as first-line but suggest reasonable adjuncts for patients seeking non-pharmacologic options; they don't contradict the standard management pathway.